DavidMichaelSwobodaMD

Oncology • Tampa, FL

Hematologic Oncology

Malignant Hematologist at TGH Cancer Institute

Join to view full profile

Dr. Swoboda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Swoboda's full profile

Already have an account?

Office
Tampa General Hospital Cancer Instititute
3 Tampa General Cir
Tampa, FL 33606
Phone+1 813-844-7585

Fax+1 561-253-3985

Summary

Dr. David Swoboda is an oncologist in Tampa, FL and is affiliated with Tampa General Hospital. He received his medical degree from Florida State University College of Medicine and has been in practice 2 years. He specializes in hematologic oncology and is experienced in acute myeloid leukemia, myeloproliferative neoplasms, myelodysplastic syndromes , and leukemia. He has more than 20 publications and over 100 citings.

Education & Training

Florida State University College of MedicineClass of 2014

Certifications & Licensure

FL State Medical License 2018 - 2026
VA State Medical License 2016 - 2020
DC State Medical License 2016 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Management of Myelodysplastic Syndrome in Pregnant Patients: Treatment Approaches and Considerations.
Erin McDonald, David M Swoboda
Seminars in Hematology. 2024-12-01
A comprehensive case study on successful multimodal therapy in philadelphia chromosome-positive acute myeloid leukemia withandmutations.
Syed Muhammad Waqar Haider, Mehwish Zehra, Nikesh N Shah, Eduardo M Sotomayor, David M Swoboda
Leukemia Research Reports. 2024-01-01
Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS).
Abhishek A Mangaonkar, David M Swoboda, Terra L Lasho, Christy Finke, Rhett P Ketterling
Leukemia Research. 2023-08-01

Journal Articles

T315I-mutated myeloid sarcoma
Yumeng Zhang, David M. Swoboda, Aditya Grover, Lisa Nodzon, Ling Zhang, Javier Pinilla-Ibarz, Leukemia Research Reports, 8/17/2019

Abstracts/Posters

OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid Leukemia
David M Swoboda, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Marrow Ring Sideroblasts Are Highly Predictive for TP53 Mutation in MDS with Excess Blasts
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019